Financial Result
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 1.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aashka Hospitals reported its H1 FY26 (April–September 2025) results. Net income from operations fell to ₹1,044.37 lakhs from ₹1,236.43 lakhs in H1 FY25, a decline of about 15.5% year-on-year. Total income dropped to ₹1,075.07 lakhs from ₹1,243.17 lakhs. Profit after tax nearly halved to ₹78 lakhs (₹0.33 per share) from ₹161.85 lakhs (₹0.69 per share) a year ago, a ~52% fall. The company recorded an exceptional item of ₹59.57 lakhs, which provided a partial cushion to earnings. On the balance sheet, trade receivables jumped sharply to ₹778.66 lakhs from ₹471.65 lakhs, while cash and cash equivalents fell steeply to ₹78.86 lakhs from ₹258.95 lakhs. Operating cash flow for the half year stood at a modest ₹37.48 lakhs.
Sharply weaker operating performance and a deteriorating cash position, alongside ballooning receivables, may pressure near-term liquidity and signal collection or demand issues. The exceptional item masks an even steeper underlying profit decline, which is negative for the stock in the short term.